Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind dose-finding study of Xinglou Chengqi Granules in acute ischemic stroke with the traditional Chinese medicine pattern of phlegm-heat fu-organ excess
CTR20254048Phase 2Active
- Sponsor
- Shanxi Zhendong Pharmaceutical Co., Ltd.
- Start
- Nov 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Xinglou Chengqi Decoction in ischemic stroke, sponsored by Shanxi Zhendong Pharmaceutical Co., Ltd.. Started Nov 2025; status: active.
02
Drugs
Xinglou Chengqi Decoction
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20254048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254048.